4Gennafi R,Curigliano G, Rotmensz N,et al. Breast carcinoma in elderlywomen : features of disease presentation, choice of local and systemictreatments compared with younger postmenopasual patients [J]. Cancer,2004,101 (6) :1302.
5Muss HB. Adjuvant therapy for ohterbreast cancer patients[J]. Breast, 2003,12 ( 6 ) :550.
6Pierga JY, Girre V, Laurence V, et al. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age[J]. Breast,2004,13 ( 5 ) : 369.
7De Michele A,Putt M,Zhang Y,et al. Older age predicts a decline in adjuvant chemotherapy recommendation for patients with breast carcinoma evidence from a tertiary care cohort of chemotherapy eligible patients [J]. Cancer, 2003,97(9):2150.
8Singh R, Hellman S, Heimann R. The natural historu, of breast carcinoma in the elderly: implication for screening and treatment[J]. Cancer, 2004,100(9 ) :1807.
9Hughes KS, Sehnaper LA, Berry. D, et at. Lumpeetomy plus tamoxifen with or without irradiation in women to years of age or older wilh early breast cancer [J]. N Engl J Med,2004,351 (10) :971.
10Oderdoal Jde V, Apffelstaedt JP. Limited surger? and tamoxifen in the treatment of elderly breast cancer patients [J]. Word J Surg, 2003,27 (2) :125.
4Ogunleye AA, Ogston SA, Evans JM, et al. A cohort study of the risk of cancer associated with type 2 diatebets[J]. Br J Cancer, 2009,101 (7) : 1199-1201.
5Curri'e C J, Poole CD, Evans M, et al. Mortality and other impor- tant diabetes-related outcomes with insulin vs other antihyper- glyeemic therapies in type 2 diabetes[J]. J Clin Endocrinol Metab, 2013,98 (2):668-677.
6Colmers IN, Bowker SL,Tjosvold LA, et ah Insulin use and can- cer risk in patients with type 2 diabetes : a systematic review and meta-analysis of observational studies[J]. Diabetes Metab, 2012, 38(6) :485-506.
7Giovannueei E, Harlan DM,Archer MC, et al. Diabetes and can- cer: a consensus report[J]. CA Cancer J Clin, 2010,60 (4) : 207-221.
8Kalli KR, Falowo OI, Bale LK, et al. Functional insulin receptors on human epithelial ovarian carcinoma cells :implications for IGF- Ⅱ mitogenic signaling[J]. Endocrinology,2002,143 (9) : 3259-3267.
9Guastamacchia E, Resta F, Triggiani V, et al. Evidence for a pu- tative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer:role of hormones ,growth factors and specific receptors[J]. Curr Drug Targets Immune En- docr Metabol Disord ,2004,4( 1 ) :59-66.
10Wu Y, Yakar S, Zhao L, et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis [J]. Cancer Res,2002,62(4) : 1030-1035.
